美国 - 英文 - NLM (National Library of Medicine)

pedinol pharmacal, inc. - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin 250 mg - gris-peg (griseofulvin ultramicrosize) is indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: trichophyton rubrum , trichophyton tonsurans, trichophyton mentagrophytes, trichophyton interdigitalis,trichophyton verrucosum, trichophyton megnini, trichophyton gallinae, trichophyton crateriform, trichophyton sulphureum, trichophyton schoenleini, microsporum audouini, microsporum canis, microsporum gypseum and epidermophyton floccosum. note: prior to therapy, the type of fungi responsible for the infection should be identified. the use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. griseofulvin is not effective in the following: bacterial inf

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential generics ltd - griseofulvin - oral tablet - 125mg

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - griseofulvin - oral tablet - 125mg

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - griseofulvin - oral tablet - 125mg

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - griseofulvin - oral tablet - 125mg

美国 - 英文 - NLM (National Library of Medicine)

rising pharmaceuticals, inc - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - ultramicrosize griseofulvin tablets, usp are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete's foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber's itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: trichophyton rubrum, trichophyton tonsurans, trichophyton mentagrophytes, trichophyton interdigitalis, trichophyton verrucosum, trichophyton megnini, trichophyton gallinae, trichophyton crateriform, trichophyton sulphureum, trichophyton schoenleini, microsporum audouini, microsporum canis, microsporum gypseum and epidermophyton floccosum . note: prior to therapy, the type of fungi responsible for the infection should be identified. the use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. griseofulvin is not effective in the following: bacterial i

美国 - 英文 - NLM (National Library of Medicine)

bimeda, inc. - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - indications equine - ringworm infection caused by trichophyton equinum and microsporum gypseum . adults - 1 packet per day (2.5 grams). yearlings - 1/2 to 1 packet per day (1.25-2.5 grams). foals - 1/2 packet per day. cases of ringworm in horses caused by t. equinum and m. gypseum should be treated with the griseofulvin powder (microsize) product for a period of not less than 10 days. responsive cases may show clinical signs of recovery in 5 to 7 days after griseofulvin therapy is initiated. in responsive cases, treatment should be continued until all infected areas are negative by appropriate culture. if cases do not respond to therapy in 3 weeks, it is recommended that the diagnosis be reevaluated. the powder may be given on a small amount of feed or in a drench.

马耳他 - 英文 - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - griseofulvin - tablet - griseofulvin 125 mg - antifungals for dermatological use

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - griseofulvin, quantity: 500 mg - tablet - excipient ingredients: sodium lauryl sulfate; povidone; maize starch; potato starch; microcrystalline cellulose; magnesium stearate - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

马耳他 - 英文 - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - griseofulvin - tablet - griseofulvin 125 mg - antifungals for dermatological use